Programmes de Marche Active et qualité de Vie Dans la Maladie de Parkinson
NCT ID: NCT05685095
Last Updated: 2023-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-02-28
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Two groups of 25 patients with PD will benefit from one of two gait training programs (treadmill vs. nordic walking), 3 times a week for 12 weeks. Activity level and number of steps will be remotely recorded over 7 days before, at the end, 3 and 6 months after the end of the program. Quality of life will be recorded at each time point.
The impact of the gait programs on the patients' level of daily activity will be examined, comparing the changes brought about by the two programs, taking into account the modulating influence of age and cognitive function.
Gait under conditions of daily life will be compared to gait parameters collected in the laboratory.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Exercise Training on Gait and Quality of Life in Parkinson's Disease
NCT01701128
Evaluation of the Impact of a Personalized Program of Adapted Physical Activates in Patients With Parkinson Disease
NCT03244813
Cycling in Parkinson's Disease
NCT02175082
Benefits of Different Exercise Types to Enhance Walking for PD
NCT04895787
A Randomised, Controlled, Open-Label, Multi-Centre Study to Evaluate the Efficacy of FeetMe® Home-Bases Rehabilitation Program in Comparison to Conventional Physiotherapy in Patients With Parkinson's Disease Using Connected Insoles
NCT05998265
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treadmill walking
The training program will last 12 weeks and consist of treadmill walking. The duration of the walking bouts (and pauses), and the speed of the belt will be adjusted as needed following the patients' progress. Music will be added as suited to boost motivation and support regular cadence. All training sessions will be supervised.
Physical training
Supervised gait training program 3 times a week, 12 weeks
Nordic walking
The training program will last 12 weeks and consist of Nordic walking, taught and supervised by an adapted physical activity teacher. The session will be carried out outside, weather permitting. When possible, training will gather 2 to 4 patients for group emulation. The duration of the walking bouts (and pauses) will be adjusted to follow the patients' progress.
Physical training
Supervised gait training program 3 times a week, 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical training
Supervised gait training program 3 times a week, 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Medical treatment (if any) unchanged in the past 4 weeks at least
* Hoehn \& Yahr score \< 3
* Montreal cognitive assessment (MOCA) score between 20 and 30
* Able to understand the aim and methods of the study and provide signed informed consent-
Exclusion Criteria
* Cardiovascular pathology preventing moderate physical exercise
* Orthostatic hypotension
* Any condition (other than PD) interfering with gait
* pregnant or nursing
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Grenoble Alps
OTHER
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Moro Elena, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Grenoble Alpes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Grenoble Alpes
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A00678-35
Identifier Type: OTHER
Identifier Source: secondary_id
38RC22.0105_ACTI-PARK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.